Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Carevive Systems, Inc. | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to use a proactive approach to improve symptom management of patients with thoracic malignancies and ensure receipt of evidence-based cancer care delivery. In this pilot study, the investigators propose to evaluate the feasibility of using outbound, proactive telephone symptom assessment strategies and ensuring evidence-based care receipt and measure the efficacy of this approach on patient satisfaction with their care, patient activation, quality of life and use of healthcare resources.
The investigators have previously shown in previous work that patients and caregivers who experience thoracic malignancies express poor symptom management that result in utilization of healthcare resources after-hours for symptoms that could have been prevented if assessed more proactively and prospectively. Currently, there are limited proactive approaches to prospectively identify and intervene on patient-reported symptoms. The purpose of this study is to enhance symptom assessment strategies by using a proactive assessment approach to improve symptom relief for patients with thoracic malignancies.
The investigators will test whether a proactive telephone symptom assessment and management strategy is feasible and can facilitate early patient report of their symptoms and intervention. The knowledge gained from this approach will be used to identify solutions that can be scaled nationally to improve patient-reported symptom management and patient satisfaction with their clinical care.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Weekly telephone symptom assessment | Experimental | Each patient who is enrolled in the intervention will receive a weekly phone call from the Research Assistant for a total of 9 months to assess symptoms using the Edmonton Symptom Assessment Scale. Results of the symptom assessments will be provided to the clinic staff (RN and MD) for review each week. Symptom assessments will be documented into an encrypted, HIPAA compliant digital platform which provides longitudinal symptom data management and also provides symptom assessment tools for the clinical team in their intervention strategies. In addition, patients will complete symptom and quality of life surveys at 0, 3, 6 and 9 months. |
|
| Control Arm | No Intervention | Patients randomized to usual clinical care will receive standard of care for thoracic malignancies as provided by the VA Palo Alto Health Care System. Patients will complete outcome surveys at 0, 3, 6, and 9 months. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Weekly telephone symptom assessment | Behavioral | Each patient who is enrolled in the intervention will receive a weekly phone call from the Research Assistant for a total of 9 months to assess symptoms using the Edmonton Symptom Assessment Scale. Results of the symptom assessments will be provided to the clinic staff (RN and MD) for review each week. Care plans will be generated using an electronic management platform |
| Measure | Description | Time Frame |
|---|---|---|
| Symptom documentation | Defined as 75% documentation of symptoms for patients in the intervention arm | 6 months after patient enrollment |
| Measure | Description | Time Frame |
|---|---|---|
| Emergency Department Visit (Chart Review) | Emergency Department visits for each patient will be abstracted by electronic medical record for each patient at 9 months | 9 months after patient enrollment |
| Hospitalizations (Chart Review) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Manali I Patel, MD | Faculty | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| VA Palo Alto Health Care System | Palo Alto | California | 94304 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 38207246 | Derived | Banks LC, Kapphahn K, Das M, Patel MI. Randomized Trial of a Volunteer-Led Symptom Assessment Intervention on Documentation, Patient-Reported Outcomes, and Health Care Use Among Veterans With Lung Cancer. JCO Oncol Pract. 2024 Mar;20(3):419-428. doi: 10.1200/OP.23.00557. Epub 2024 Jan 11. | |
| 35669484 | Derived |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D008175 | Lung Neoplasms |
| ID | Term |
|---|---|
| D012142 | Respiratory Tract Neoplasms |
| D013899 | Thoracic Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
Hospitalizations for each patient will be abstracted by electronic medical record for each patient at 9 months
| 9 months after patient enrollment |
| Change in Quality of Life using the Functional Assessment of Cancer Therapy - Lung survey | Each patient will receive a validated survey to assess quality of life at baseline and 3 months | Change in Quality of Life from baseline to month 3 |
| Change in Quality of Life using the Functional Assessment of Cancer Therapy - Lung survey | Each patient will receive a validated survey to assess quality of life at baseline and 6 months | Change in Quality of Life from baseline to month 6 |
| Change in Quality of Life using the Functional Assessment of Cancer Therapy - Lung survey | Each patient will receive a validated survey to assess quality of life at baseline and 9 months | Change in Quality of Life from baseline to month 9 |
| Change in patient satisfaction with decision-making using the Satisfaction with Decision Survey | Each patient will receive a validated survey to assess their satisfaction with decision at baseline and 3 months | Change in patient satisfaction with decision--making from baseline to 3 months |
| Change in patient satisfaction with decision-making using the Satisfaction with Decision Survey | Each patient will receive a validated survey to assess their satisfaction with decision at baseline and 6 months | Change in patient satisfaction with decision--making from baseline to 6 months |
| Change in patient satisfaction with decision-making using the Satisfaction with Decision Survey | Each patient will receive a validated survey to assess their satisfaction with decision at baseline and 9 months | Change in patient satisfaction with decision--making from baseline to 9 months |
| Change in Patient Activation using the validated Patient Activation Measure | Each patient will receive a validated survey to assess their activation at baseline and 3 months | Change in patient activation from baseline to 3 months |
| Change in Patient Activation using the validated Patient Activation Measure | Each patient will receive a validated survey to assess their activation at baseline and 6 months | Change in patient activation from baseline to 6 months |
| Change in Patient Activation using the validated Patient Activation Measure | Each patient will receive a validated survey to assess their activation at baseline and 9 months | Change in patient activation from baseline to 9 months |
| Change in symptoms using the validated Edmonton Symptom Assessment Scale | Each patient will receive a validated survey to assess their symptoms at baseline and 3 months | Change in symptoms from baseline to 3 months |
| Change in symptoms using the validated Edmonton Symptom Assessment Scale | Each patient will receive a validated survey to assess their symptoms at baseline and 6 months | Change in symptoms from baseline to 6 months |
| Change in symptoms using the validated Edmonton Symptom Assessment Scale | Each patient will receive a validated survey to assess their symptoms at baseline and 9 months | Change in symptoms from baseline to 9 months |
| Patel MI, Banks L, Das M. Improving supportive care for patients with Thoracic Malignancies - A randomized controlled trial. Contemp Clin Trials Commun. 2022 May 27;28:100929. doi: 10.1016/j.conctc.2022.100929. eCollection 2022 Aug. |
| D008171 |
| Lung Diseases |
| D012140 | Respiratory Tract Diseases |